MIR sales rose 3% in Q2; H1 profit targets out of reach
MIR said sales rose 3% in Q2 and recurring revenues surged, but H1 profit targets remain out of reach.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.